Real Estate / REIT - Healthcare FacilitiesTel Aviv
$3694.00
+34.00 (+0.93%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 100% · confianza 20%
FCF escenarios
weak_data · normalized FCF n/d · quality 100.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
33/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$496M
P/E
20.4x
↑EV/EBITDA
366.5x
↑ROE
62.6%
↑Gross Margin
89.8%
↑Debt/Equity
65.37
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+18.8%
FCF CAGR
+20.9%
FCF margin
58.1%
FCF / Net income
11.89x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $155.0M · net income $7.6M · FCF $90.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $155.0M | $155.0M | $117.1M | $99.8M | $92.5M |
| Net Income | $7.6M | $7.6M | $4.1M | $2.5M | $1.9M |
| EBITDA | $130.1M | $130.1M | $94.3M | $75.2M | $66.4M |
| EPS | 0.60 | 0.60 | 0.57 | 0.39 | 0.31 |
| Gross Margin | 89.8% | 89.8% | 87.0% | 85.0% | 85.2% |
| Operating Margin | 53.4% | 53.4% | 51.0% | 48.3% | 52.1% |
| Net Margin | 4.9% | 4.9% | 3.5% | 2.5% | 2.0% |
| Balance Sheet | |||||
| Debt/Equity | 65.37 | 65.37 | 36.97 | 71.66 | 58.73 |
| Current Ratio | 0.47 | 0.47 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $90.0M | $90.0M | $35.3M | $54.9M | $50.9M |
| Returns | |||||
| ROE | 62.6% | 62.6% | 22.5% | 33.2% | 23.8% |
| Valuation | |||||
| P/E | 20.41 | 20.41 | 6801.75 | — | — |
| EV/EBITDA | 366.46 | 366.46 | 299.38 | — | — |
| P/B | 3874.28 | 3874.28 | 1520.28 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 32.4% | 32.4% | 17.3% | 7.8% | — |
| EPS Growth | 5.3% | 5.3% | 46.2% | 25.8% | — |
| Dividend Yield | 5.4% | 5.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
717.5%
EPS terminal req.
$327.78
Spread vs growth
-712.2%
5Y implied EPS CAGR
266.5%
EPS terminal req.
$396.61
Spread vs growth
-261.2%
10Y implied EPS CAGR
100.8%
EPS terminal req.
$638.75
Spread vs growth
-95.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-8.4%
Start / end P/E
7519.3x → 6156.7x
EPS bridge
0.57 → 0.60
Residual
-1.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.